Patient Adherence to Osteoporosis Medications
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 24 (1) , 37-55
- https://doi.org/10.2165/00002512-200724010-00003
Abstract
Adherence to osteoporosis medications is relatively poor. Approximately 20–30% of patients taking daily or weekly treatments may suspend their treatment within 6 to 12 months of initiating therapy....Keywords
This publication has 88 references indexed in Scilit:
- Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyAnnals of the Rheumatic Diseases, 2006
- Calcium plus Vitamin D Supplementation and the Risk of FracturesNew England Journal of Medicine, 2006
- Long-term Outcome of Weekly BisphosphonatesClinical Orthopaedics and Related Research, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosisClimacteric, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986
- Can simple clinical measurements detect patient noncompliance?Hypertension, 1980